Neural precursor cell-expressed developmentally down-regulated 4-like: a new biomarker in the pathophysiology of endometrial cancer

Objectives Endometrial cancer is the most frequent tumor of the female genital tract. Ubiquitin is a small protein (8.5 kDa) found in all eukaryotic cells, binds to substrate proteins via a three-phase enzymatic pathway referred to as ubiquitination and plays an important role in cellular stability. Neural precursor cell-expressed developmentally down-regulated 4-like (NEDD4L) functions in the last phase of this enzymatic process. In this study, we investigated NEDD4L protein expression in endometrial cancer. Methods The study participants were divided into patients with benign endometrial pathologies (Group 1, n = 23), patients with endometrial hyperplasia (Group 2, n = 21) and patients with endometrial cancer (Group 3, n = 20). NEDD4L expression was detected by immunohistochemical staining and H scores were calculated to standardize staining intensity. Statistical analysis was performed using SPSS 16.0. Results NEDD4L expression levels according to H scores were significantly lower in patients diagnosed with endometrial cancer compared with those with benign endometrial pathologies. Conclusion NEDD4L is involved in maintaining cell stability, and reduced NEDD4L expression as a result of gene mutation may disrupt this balance in favor of tumorigenesis.

[1]  Q. Shi,et al.  β-transducin repeat-containing E3 ubiquitin protein ligase inhibits migration, invasion and proliferation of glioma cells. , 2017, Oncology letters.

[2]  Alexander Varshavsky,et al.  The Ubiquitin System, Autophagy, and Regulated Protein Degradation. , 2017, Annual review of biochemistry.

[3]  D. Srivastava,et al.  The E3 ubiquitin ligase Nedd4/Nedd4L is directly regulated by microRNA 1 , 2017, Development.

[4]  M. Cui,et al.  Nedd4L expression is decreased in ovarian epithelial cancer tissues compared to ovarian non‐cancer tissue , 2015, The journal of obstetrics and gynaecology research.

[5]  J. Kwon.  Improving survival after endometrial cancer: the big picture , 2015, Journal of gynecologic oncology.

[6]  G. Pond,et al.  Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome. , 2015, Obstetrics and gynecology.

[7]  P. Goel,et al.  NEDD4-2 (NEDD4L): the ubiquitin ligase for multiple membrane proteins. , 2015, Gene.

[8]  X. Chen,et al.  NEDD4L Is Downregulated in Colorectal Cancer and Inhibits Canonical WNT Signaling , 2013, PloS one.

[9]  K. Mimori,et al.  Identification of the NEDD4L Gene as a Prognostic Marker by Integrated Microarray Analysis of Copy Number and Gene Expression Profiling in Non-small Cell Lung Cancer , 2013, Annals of Surgical Oncology.

[10]  T. Kleyman,et al.  Epithelial Na(+) channel regulation by cytoplasmic and extracellular factors. , 2012, Experimental cell research.

[11]  Y. Tu,et al.  Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma. , 2012, Japanese journal of clinical oncology.

[12]  C. Ren,et al.  Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient , 2012, Medical Oncology.

[13]  M. Furihata,et al.  Nedd4L modulates the transcription of metalloproteinase‐1 and ‐13 genes to increase the invasive activity of gallbladder cancer , 2011, International journal of experimental pathology.

[14]  T. Schlomm,et al.  Transcription alterations of members of the ubiquitin–proteasome network in prostate carcinoma , 2011, Prostate Cancer and Prostatic Diseases.

[15]  J. Huang,et al.  Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  K. Hallows,et al.  Mechanisms of ENaC regulation and clinical implications. , 2008, Journal of the American Society of Nephrology : JASN.

[17]  J. Utikal,et al.  Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3 , 2008, Leukemia.

[18]  K. Miyazono,et al.  NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-β (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor , 2005 .

[19]  K. Miyazono,et al.  NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor. , 2005, The Biochemical journal.

[20]  F. McMahon,et al.  NEDD4L on human chromosome 18q21 has multiple forms of transcripts and is a homologue of the mouse Nedd4-2 gene , 2001, European Journal of Human Genetics.

[21]  D. Mutch,et al.  Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. , 1986, Cancer research.